Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antithymocyte Globulin”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT07670650
What this trial is testing

PRISE (Personalized Response and Immunologic Surveillance of Endogenous C-Peptide Preservation in New, Recent, and Established Onset Type 1 Diabetes Treated With Human Anti-Thymocyte Globulin [h-ATG]) Study

Who this might be right for
Type 1 Diabetes (T1D)
University of Florida 108
Post-approval studies (Phase 4)Study completedNCT00331162
What this trial is testing

Study of Alemtuzumab Versus Anti-thymocyte Globulin to Help Prevent Rejection in Kidney and Pancreas Transplantation

Who this might be right for
Graft Rejection
Wake Forest University Health Sciences 222
Testing effectiveness (Phase 2)Ended earlyNCT00515099
What this trial is testing

Study of Antithymocyte Globulin for Treatment of New-onset T1DM

Who this might be right for
New-onset Type 1 Diabetes Mellitus
National Institute of Allergy and Infectious Diseases (NIAID) 58
Testing effectiveness (Phase 2)UnknownNCT06238245
What this trial is testing

Combination of ATG-based Conditioning Regimen and PTCy for GVHD Prevention in Allo-HSCT After PD-1 Blockade

Who this might be right for
Graft-versus-host DiseaseHematological Malignancies
Beijing 302 Hospital 22
Not applicableUnknownNCT05199103
What this trial is testing

Antithymocyte Globulin as a Second Line Therapy in Graves Orbitopathy

Who this might be right for
Graves Orbitopathy
Medical University of Silesia 20
Large-scale testing (Phase 3)Study completedNCT00774527
What this trial is testing

Comparison of Cy-Atg Vs Cy-Flu-Atg for the Conditioning Therapy in Allo-HCT

Who this might be right for
Bone Marrow Failure Syndromes
Cooperative Study Group A for Hematology 82
Not applicableLooking for participantsNCT06041893
What this trial is testing

Haploidentical Hematopoietic Stem Cell Transplantation With Early ATG and Low Dose Post-transplant Cyclophosphamide

Who this might be right for
Haploidentical Hematopoietic Stem Cell Transplantation
Samsung Medical Center 20
Testing effectiveness (Phase 2)Study completedNCT00016419
What this trial is testing

S0020 Immunosuppressive Therapy in Treating Patients With Myelodysplastic Syndrome

Who this might be right for
LeukemiaMyelodysplastic Syndromes
SWOG Cancer Research Network 130
Testing effectiveness (Phase 2)Study completedNCT01106157
What this trial is testing

Reversing Type 1 Diabetes After it is Established

Who this might be right for
Diabetes Mellitus, Type 1
University of Florida 25
Large-scale testing (Phase 3)Study completedNCT00004474
What this trial is testing

Phase III Randomized Study of Cyclophosphamide With or Without Antithymocyte Globulin Before Bone Marrow Transplantation in Patients With Aplastic Anemia

Who this might be right for
Aplastic Anemia
Roswell Park Cancer Institute 224
Post-approval studies (Phase 4)UnknownNCT00693446
What this trial is testing

Compare Sirolimus Versus Tacrolimus In De Novo Simultaneous Pancreas- Kidney Allograft Recipients Receiving An Induction Therapy With Antithymocyte Globulin Plus Mycophenolate Mofetil Plus Corticosteroids

Who this might be right for
Pancreas TransplantationKidney Transplantation
Nantes University Hospital 118
Early research (Phase 1)Looking for participantsNCT03591302
What this trial is testing

Delayed Blood Stem Transplantation in HLA Matched Kidney Transplant Recipients to Eliminate Immunosuppressive Drugs.

Who this might be right for
Immune Tolerance
Stephan Busque 25
Testing effectiveness (Phase 2)UnknownNCT00319657
What this trial is testing

Kidney and Blood Stem Cell Transplantation That Eliminates Requirement for Immunosuppressive Drugs

Who this might be right for
Immune Tolerance
Stanford University 15
Post-approval studies (Phase 4)Study completedNCT03006419
What this trial is testing

Basiliximab vs Low-dose Thymoglobulin Induction Therapy in Low Risk Kidney Transplant Patients

Who this might be right for
Kidney Transplant RejectionKidney Transplant; Complications
Coordinación de Investigación en Salud, Mexico 100
Testing effectiveness (Phase 2)Study completedNCT04328727
What this trial is testing

Combination of Eltrombopag With Immunosuppressive Therapy in East-Asian Patients With Severe Aplastic Anemia

Who this might be right for
Severe Aplastic Anemia (SAA)
Novartis Pharmaceuticals 36
Testing effectiveness (Phase 2)Study completedNCT00691015
What this trial is testing

Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplant

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+3 more
Barbara Ann Karmanos Cancer Institute 48
Large-scale testing (Phase 3)Study completedNCT00004208
What this trial is testing

Antithymocyte Globulin and Cyclosporine in Treating Patients With Myelodysplastic Syndrome

Who this might be right for
Myelodysplastic Syndromes
Swiss Cancer Institute 86
Testing effectiveness (Phase 2)Study completedNCT01566656
What this trial is testing

Allogeneic Hematopoietic Stem Cell Transplantation Using a Non-myeloablative Preparative Regimen of Total Lymphoid Irradiation and Anti-thymocyte Globulin for Older Patients With Relapsed Lymphoid Malignancies

Who this might be right for
Haemato-lymphoid Malignancies or Syndromes in Whom Allogeneic Stem Cell Transplantation is Warranted
Nantes University Hospital 15
Testing effectiveness (Phase 2)Looking for participantsNCT06455319
What this trial is testing

Precision Administration of Anti-thymocyte Globulin With or Without Verapamil

Who this might be right for
Type 1 Diabetes
University of Florida 60
Testing effectiveness (Phase 2)UnknownNCT01154387
What this trial is testing

Evaluating Safety and Efficacy of TOL101 Induction Versus Anti-Thymocyte Globulin to Prevent Kidney Transplant Rejection

Who this might be right for
End Stage Renal DiseaseRenal Transplant
Tolera Therapeutics, Inc 85
Next Page